Advertisements


Psychoanalysing NATO: Projection

Authored by Patrick Armstrong via The Strategic Culture Foundation, "NATO" can be a rather elusive concept: Libya was a NATO operation, even though Germany kept out of it. Somalia was not a NATO operation even though Germany.....»»

Category: blogSource: zerohedgeJul 4th, 2018

Cummins (CMI) Stock Sinks As Market Gains: What You Should Know

Cummins (CMI) closed the most recent trading day at $227.66, moving -0.29% from the previous trading session. Cummins (CMI) closed at $227.66 in the latest trading session, marking a -0.29% move from the prior day. This change lagged the S&P 500's 0.15% gain on the day.Prior to today's trading, shares of the engine maker had lost 3.65% over the past month. This has lagged the Auto-Tires-Trucks sector's gain of 4.96% and the S&P 500's loss of 0.58% in that time.Investors will be hoping for strength from CMI as it approaches its next earnings release. The company is expected to report EPS of $4.23, up 18.49% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $6.09 billion, up 19.04% from the year-ago period.CMI's full-year Zacks Consensus Estimates are calling for earnings of $16.37 per share and revenue of $24.65 billion. These results would represent year-over-year changes of +36.3% and +24.41%, respectively.Any recent changes to analyst estimates for CMI should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. CMI is currently a Zacks Rank #3 (Hold).Valuation is also important, so investors should note that CMI has a Forward P/E ratio of 13.95 right now. This represents a premium compared to its industry's average Forward P/E of 13.01.Also, we should mention that CMI has a PEG ratio of 1.25. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Automotive - Internal Combustion Engines stocks are, on average, holding a PEG ratio of 1.25 based on yesterday's closing prices.The Automotive - Internal Combustion Engines industry is part of the Auto-Tires-Trucks sector. This industry currently has a Zacks Industry Rank of 125, which puts it in the top 50% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.To follow CMI in the coming trading sessions, be sure to utilize Zacks.com. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cummins Inc. (CMI): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 24th, 2021

Nvidia (NVDA) Stock Sinks As Market Gains: What You Should Know

Nvidia (NVDA) closed the most recent trading day at $220.81, moving -1.78% from the previous trading session. In the latest trading session, Nvidia (NVDA) closed at $220.81, marking a -1.78% move from the previous day. This move lagged the S&P 500's daily gain of 0.15%.Coming into today, shares of the maker of graphics chips for gaming and artificial intelligence had gained 1.88% in the past month. In that same time, the Computer and Technology sector gained 0.81%, while the S&P 500 lost 0.58%.Wall Street will be looking for positivity from NVDA as it approaches its next earnings report date. On that day, NVDA is projected to report earnings of $1.11 per share, which would represent year-over-year growth of 52.05%. Meanwhile, our latest consensus estimate is calling for revenue of $6.83 billion, up 44.46% from the prior-year quarter.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $4.20 per share and revenue of $25.81 billion. These totals would mark changes of +68% and +54.79%, respectively, from last year.Investors might also notice recent changes to analyst estimates for NVDA. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.08% higher. NVDA is currently sporting a Zacks Rank of #2 (Buy).Digging into valuation, NVDA currently has a Forward P/E ratio of 53.54. For comparison, its industry has an average Forward P/E of 23.36, which means NVDA is trading at a premium to the group.We can also see that NVDA currently has a PEG ratio of 2.74. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Semiconductor - General stocks are, on average, holding a PEG ratio of 2.73 based on yesterday's closing prices.The Semiconductor - General industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 55, putting it in the top 22% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.To follow NVDA in the coming trading sessions, be sure to utilize Zacks.com. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NVIDIA Corporation (NVDA): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

Palantir Technologies Inc. (PLTR) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Palantir Technologies Inc. (PLTR) closed at $28.56, marking a -0.73% move from the previous day. In the latest trading session, Palantir Technologies Inc. (PLTR) closed at $28.56, marking a -0.73% move from the previous day. This move lagged the S&P 500's daily gain of 0.15%.Heading into today, shares of the company had gained 15.68% over the past month, outpacing the Business Services sector's gain of 1.13% and the S&P 500's loss of 0.58% in that time.PLTR will be looking to display strength as it nears its next earnings release. On that day, PLTR is projected to report earnings of $0.04 per share, which would represent a year-over-year decline of 55.56%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $385 million, up 33.05% from the year-ago period.PLTR's full-year Zacks Consensus Estimates are calling for earnings of $0.16 per share and revenue of $1.5 billion. These results would represent year-over-year changes of -15.79% and +37.48%, respectively.Investors should also note any recent changes to analyst estimates for PLTR. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. PLTR is currently a Zacks Rank #3 (Hold).Investors should also note PLTR's current valuation metrics, including its Forward P/E ratio of 185.61. For comparison, its industry has an average Forward P/E of 29.67, which means PLTR is trading at a premium to the group.The Technology Services industry is part of the Business Services sector. This industry currently has a Zacks Industry Rank of 223, which puts it in the bottom 13% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Palantir Technologies Inc. (PLTR): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

Diamondback Energy (FANG) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Diamondback Energy (FANG) closed at $88.72, marking a +0.98% move from the previous day. In the latest trading session, Diamondback Energy (FANG) closed at $88.72, marking a +0.98% move from the previous day. This change outpaced the S&P 500's 0.15% gain on the day.Prior to today's trading, shares of the energy exploration and production company had gained 20.22% over the past month. This has outpaced the Oils-Energy sector's gain of 7.33% and the S&P 500's loss of 0.58% in that time.Wall Street will be looking for positivity from FANG as it approaches its next earnings report date. On that day, FANG is projected to report earnings of $2.64 per share, which would represent year-over-year growth of 325.81%. Our most recent consensus estimate is calling for quarterly revenue of $1.48 billion, up 106.12% from the year-ago period.FANG's full-year Zacks Consensus Estimates are calling for earnings of $10.14 per share and revenue of $5.5 billion. These results would represent year-over-year changes of +233.55% and +95.41%, respectively.Any recent changes to analyst estimates for FANG should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.21% higher. FANG is currently a Zacks Rank #3 (Hold).In terms of valuation, FANG is currently trading at a Forward P/E ratio of 8.67. This valuation marks a discount compared to its industry's average Forward P/E of 9.64.Investors should also note that FANG has a PEG ratio of 0.4 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Oil and Gas - Exploration and Production - United States industry currently had an average PEG ratio of 0.41 as of yesterday's close.The Oil and Gas - Exploration and Production - United States industry is part of the Oils-Energy sector. This industry currently has a Zacks Industry Rank of 56, which puts it in the top 23% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Diamondback Energy, Inc. (FANG): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 24th, 2021

Devon Energy (DVN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Devon Energy (DVN) closed at $33.09, marking a +0.88% move from the previous day. Devon Energy (DVN) closed the most recent trading day at $33.09, moving +0.88% from the previous trading session. This change outpaced the S&P 500's 0.15% gain on the day.Coming into today, shares of the oil and gas exploration company had gained 12.75% in the past month. In that same time, the Oils-Energy sector gained 7.33%, while the S&P 500 lost 0.58%.Investors will be hoping for strength from DVN as it approaches its next earnings release, which is expected to be November 2, 2021. In that report, analysts expect DVN to post earnings of $0.86 per share. This would mark year-over-year growth of 2250%. Meanwhile, our latest consensus estimate is calling for revenue of $3.02 billion, up 183.28% from the prior-year quarter.For the full year, our Zacks Consensus Estimates are projecting earnings of $2.77 per share and revenue of $10.47 billion, which would represent changes of +3177.78% and +116.89%, respectively, from the prior year.It is also important to note the recent changes to analyst estimates for DVN. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.91% higher. DVN is holding a Zacks Rank of #3 (Hold) right now.Looking at its valuation, DVN is holding a Forward P/E ratio of 11.84. This valuation marks a premium compared to its industry's average Forward P/E of 9.64.It is also worth noting that DVN currently has a PEG ratio of 0.37. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. DVN's industry had an average PEG ratio of 0.41 as of yesterday's close.The Oil and Gas - Exploration and Production - United States industry is part of the Oils-Energy sector. This group has a Zacks Industry Rank of 56, putting it in the top 23% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Devon Energy Corporation (DVN): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

Peloton (PTON) Stock Sinks As Market Gains: What You Should Know

Peloton (PTON) closed at $92.64 in the latest trading session, marking a -1.84% move from the prior day. Peloton (PTON) closed the most recent trading day at $92.64, moving -1.84% from the previous trading session. This change lagged the S&P 500's 0.15% gain on the day.Coming into today, shares of the exercise bike and treadmill company had lost 17.28% in the past month. In that same time, the Consumer Discretionary sector gained 0.41%, while the S&P 500 lost 0.58%.Wall Street will be looking for positivity from PTON as it approaches its next earnings report date. The company is expected to report EPS of -$1.15, down 675% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $802.71 million, up 5.91% from the year-ago period.PTON's full-year Zacks Consensus Estimates are calling for earnings of -$1.98 per share and revenue of $5.37 billion. These results would represent year-over-year changes of -209.38% and +33.6%, respectively.Any recent changes to analyst estimates for PTON should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 512.12% lower. PTON is currently sporting a Zacks Rank of #5 (Strong Sell).The Leisure and Recreation Products industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 30, putting it in the top 12% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Peloton Interactive, Inc. (PTON): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

Penn National Gaming (PENN) Outpaces Stock Market Gains: What You Should Know

Penn National Gaming (PENN) closed at $75.72 in the latest trading session, marking a +0.16% move from the prior day. Penn National Gaming (PENN) closed the most recent trading day at $75.72, moving +0.16% from the previous trading session. This change outpaced the S&P 500's 0.15% gain on the day.Coming into today, shares of the casino operator had lost 6.48% in the past month. In that same time, the Consumer Discretionary sector gained 0.41%, while the S&P 500 lost 0.58%.Wall Street will be looking for positivity from PENN as it approaches its next earnings report date. The company is expected to report EPS of $0.81, down 12.9% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.5 billion, up 32.76% from the year-ago period.PENN's full-year Zacks Consensus Estimates are calling for earnings of $3.21 per share and revenue of $5.73 billion. These results would represent year-over-year changes of +164.2% and +60.01%, respectively.Any recent changes to analyst estimates for PENN should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. PENN is currently sporting a Zacks Rank of #3 (Hold).Looking at its valuation, PENN is holding a Forward P/E ratio of 23.59. Its industry sports an average Forward P/E of 22.38, so we one might conclude that PENN is trading at a premium comparatively.The Gaming industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 181, putting it in the bottom 29% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Penn National Gaming, Inc. (PENN): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

Vishay Intertechnology (VSH) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Vishay Intertechnology (VSH) closed at $20.73, marking a +1.02% move from the previous day. Vishay Intertechnology (VSH) closed at $20.73 in the latest trading session, marking a +1.02% move from the prior day. This change outpaced the S&P 500's 0.15% gain on the day.Prior to today's trading, shares of the chipmaker had lost 5.83% over the past month. This has lagged the Computer and Technology sector's gain of 0.81% and the S&P 500's loss of 0.58% in that time.Wall Street will be looking for positivity from VSH as it approaches its next earnings report date. On that day, VSH is projected to report earnings of $0.67 per share, which would represent year-over-year growth of 168%. Our most recent consensus estimate is calling for quarterly revenue of $834.1 million, up 30.3% from the year-ago period.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $2.36 per share and revenue of $3.24 billion. These totals would mark changes of +156.52% and +29.31%, respectively, from last year.Investors should also note any recent changes to analyst estimates for VSH. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. VSH currently has a Zacks Rank of #2 (Buy).Investors should also note VSH's current valuation metrics, including its Forward P/E ratio of 8.71. For comparison, its industry has an average Forward P/E of 15.38, which means VSH is trading at a discount to the group.Investors should also note that VSH has a PEG ratio of 0.36 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Semiconductor - Discretes industry currently had an average PEG ratio of 0.36 as of yesterday's close.The Semiconductor - Discretes industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 59, putting it in the top 24% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Vishay Intertechnology, Inc. (VSH): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

3 Tips To Help Junior Partners Avoid Lifestyle Creep

Lifestyle creep, or lifestyle inflation – when expenses rapidly rise to match newfound income – ensnares countless newly minted partners. Often there are underlying social pressures from peers or colleagues to keep up with new levels of conspicuous consumption. New indulgences and one-time splurges quickly become everyday necessities. It may begin innocently enough with a […] Lifestyle creep, or lifestyle inflation – when expenses rapidly rise to match newfound income – ensnares countless newly minted partners. Often there are underlying social pressures from peers or colleagues to keep up with new levels of conspicuous consumption. New indulgences and one-time splurges quickly become everyday necessities. It may begin innocently enough with a new car, a small remodel to an existing home, or a generous contribution to one’s alma mater, but it can quickly snowball into completely spending bonus checks before they have even been deposited. if (typeof jQuery == 'undefined') { document.write(''); } .first{clear:both;margin-left:0}.one-third{width:31.034482758621%;float:left;margin-left:3.448275862069%}.two-thirds{width:65.51724137931%;float:left}form.ebook-styles .af-element input{border:0;border-radius:0;padding:8px}form.ebook-styles .af-element{width:220px;float:left}form.ebook-styles .af-element.buttonContainer{width:115px;float:left;margin-left: 6px;}form.ebook-styles .af-element.buttonContainer input.submit{width:115px;padding:10px 6px 8px;text-transform:uppercase;border-radius:0;border:0;font-size:15px}form.ebook-styles .af-body.af-standards input.submit{width:115px}form.ebook-styles .af-element.privacyPolicy{width:100%;font-size:12px;margin:10px auto 0}form.ebook-styles .af-element.privacyPolicy p{font-size:11px;margin-bottom:0}form.ebook-styles .af-body input.text{height:40px;padding:2px 10px !important} form.ebook-styles .error, form.ebook-styles #error { color:#d00; } form.ebook-styles .formfields h1, form.ebook-styles .formfields #mg-logo, form.ebook-styles .formfields #mg-footer { display: none; } form.ebook-styles .formfields { font-size: 12px; } form.ebook-styles .formfields p { margin: 4px 0; } Get The Full Henry Singleton Series in PDF Get the entire 4-part series on Henry Singleton in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues (function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]='EMAIL';ftypes[0]='email';}(jQuery));var $mcj = jQuery.noConflict(true); Q2 2021 hedge fund letters, conferences and more So, who cares? After all, you have sacrificed a lot to get where you are today and rewarding yourself for a job well done is your right. However, many junior partners have not considered what they are giving up by having their expenses match their income – namely, true financial freedom or the ability to say no. It is difficult to downshift your lifestyle, especially if you have no resources to fall back on other than your future earning potential. Make sure you do not find yourself in this situation by following these tips. Prepare for Lumpy Cash Flow It is important to be fiscally prepared for lumpy cash flow – expenses like estimated tax payments, firm capital commitments, and new firm sponsorship contributions, just to name a few, can potentially catch you off-guard. Without adequate planning and forethought, you can find yourself flat-footed at a very inopportune moment. The first step to addressing lifestyle creep is to be prepared. Create a short-term cash strategy to help you avoid common cashflow missteps. Start by identifying what your major outstanding liabilities will likely be for the next 12 months. After you have identified these cash needs find a ready source of liquidity to cover them. When reviewing your cash strategy look for potential mismatches between liabilities and cash flow, consider all your options. Be prepared to cover an unexpected expense in addition to the ones you identified. Remember alternative sources of potential liquidity that you could use to smooth over any cash crunches, such as: A margin loan against assets held in investment accounts. A cash reserve built up over the course of time specifically for these types of surprise liquidity events. Short term financing solutions offered by the firm. If you do not research your options in advance, it is difficult to know in the moment what your best options is. Sometimes the terms of short-term margin loans are equal or better than terms offered to new partners from other sources sometime not – having options in place and knowing what they are is paramount to helping you address your need when it arises. Preparing a short-term cash strategy will give you a better sense of what to hold in reserves for future expenditures, what you can spend on your current lifestyle needs, and what to invest for long-term growth – allowing you to avoid the trap of lifestyle inflation. Identify Your Goals and Values Making conscious decisions about what is important to you is one of the most crucial steps in combating lifestyle inflation. You may really like the idea of: Having the option to slow down when you want to. Buying a vacation home to spend quality time with family. Providing meaningful philanthropic support to a cause you believe in. Being able to offer monetary support to aging parents. There are no right or wrong choices, but you should make a choice. One of my favorite quotes is, “If you don’t know where you are going, you might wind up someplace else.” Not having your long-term goals well-defined makes it easier to succumb to lifestyle creep, potentially leaving you someplace you didn’t intend to be. Balancing short-term needs with long-term goals is a lifelong pursuit, so it is vital not to focus solely on one or the other at any given time. Clearly outlining your goals and having a financial plan in place to achieve them will help you feel comfortable living the life you want today, knowing you are going to end up where you truly want to be. Create a Financial Roadmap Without knowing what you are aiming at, you can miss your target and let other seemingly pressing things drain your ability to accomplish what you really want. After identifying what matters most to you, the next step is to create a financial roadmap to help guide you to your destination. This is done through a comprehensive financial plan that considers not only your resources and liabilities, but also incorporates an in-depth cash flow and investment return projection as well. Having your plan in place will help guide you towards your goals and remind you to maintain focus on them. To create a financial roadmap, you should gather and review information regarding: Partner Benefits: 401(k), deferred compensations plans, etc. Investment Assets: taxable and retirement accounts, physical assets, etc. Liabilities: existing mortgages, home equity lines of credit (HELOCs), credit cards, student loans, etc. Insurance: personal and group benefits – disability, life, property & casualty, etc. Estate Plan: current wills, Powers of Attorney (POAs), revocable and irrevocable trusts, etc. Tax Returns: recent returns from your accountant for reviewing income, expenses, deductions, etc. These data points allow you to create a more meaningful individual guide to help you stay on track to reach your financial goals. As assets and income projections change, risk profiles are modified, and other aspects of your personal and financial life develop with time, you should revisit and adjust your financial roadmap to reflect your new situation and goals. Your financial roadmap is a living document that will always be there to reorient you, helping to combat lifestyle creep. Conclusion Some level of lifestyle inflation is inevitable and necessary, continuing to live like you are a first-year associate is not the answer to preventing lifestyle creep. As with most things in life, the key is moderation. The transition to partner can be a challenging one – creating a comprehensive financial roadmap that takes your personal and professional situation and goals into consideration is the best way to develop and implement a plan that will help you avoid the kind of overextension that could materially impact your ability to achieve what you really want – whatever you decide that is. About the Author Eric Dostal, J.D., CFP®, Vice President at Wealthspire Advisors, works extensively with clients to help them feel in control of their financial lives. Eric has demonstrated a high degree of skill developing and overseeing the investment, insurance, retirement, tax and estate planning strategies of his clients. He seeks to understand a clients’ unique financial circumstances, get them organized and on the path to financial independence. Wealthspire Advisors LLC is a registered investment adviser and subsidiary company of NFP Corp. Certified Financial Planner Board of Standards, Inc. (CFP Board) owns the certification marks CFP®, Certified Financial Planner, and CFP® (with plaque design) in the United States, which it authorizes use of by individuals who successfully complete CFP Board’s initial and ongoing certification requirements. This information should not be construed as a recommendation, offer to sell, or solicitation of an offer to buy a particular security or investment strategy. The commentary provided is for informational purposes only and should not be relied upon for accounting, legal, or tax advice. While the information is deemed reliable, Wealthspire Advisors cannot guarantee its accuracy, completeness, or suitability for any purpose, and makes no warranties with regard to the results to be obtained from its use. ©2021 Wealthspire Advisors. Updated on Sep 24, 2021, 4:05 pm (function() { var sc = document.createElement("script"); sc.type = "text/javascript"; sc.async = true;sc.src = "//mixi.media/data/js/95481.js"; sc.charset = "utf-8";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(sc, s); }()); window._F20 = window._F20 || []; _F20.push({container: 'F20WidgetContainer', placement: '', count: 3}); _F20.push({finish: true});.....»»

Category: blogSource: valuewalkSep 24th, 2021

Here"s Why You Should Retain Insulet (PODD) Stock for Now

Strong domestic and international performance by Omnipod is driving the top line for Insulet (PODD). Insulet Corporation PODD is well poised for growth in the coming quarters, backed by Omnipod’s U.S. and international expansion. The company ended the second quarter of 2021 with better-than-expected revenues. A good solvency position is another advantage. The company’s plan to launch the Omnipod 5 buoys optimism. However, macroeconomic woes and stiff competition do not bode well for the stock.Over the past year, the Zacks Rank #3 (Hold) stock has gained 34.2% against 15.3% growth of the industry and a 37.3% rise of the S&P 500.The renowned developer, manufacturer and marketer of insulin delivery system has a market capitalization of $20.02 billion.The company projects 620% growth for 2022 and expects to maintain its strong segmental performance. It surpassed estimates in one of the trailing four quarters and missed in three, the average negative surprise being 66.7%.Image Source: Zacks Investment ResearchLet’s delve deeper.Factors At PlayOmnipod’s Continued Market Access Expansion: Insulet is consistently gaining from the full commercial launch of the Omnipod DASH system in the United States in 2019, raising optimism. During the second quarter of 2021, the company registered strong U.S. Omnipod revenue growth led by an expanding customer base, Omnipod DASH adoption and ongoing mix benefit as the company shifts volume into the pharmacy channel. Omnipod DASH, which continues to drive growth, drove almost 80% of the U.S. new customer addition in the second quarter of 2021. We are upbeat about the launch of Omnipod DASH system in Canada in January 2021. Further, the company’s plans to launch Omnipod DASH in Australia in 2021, thereby building on its expansion into Turkey during early 2021 and across Europe and the Middle East in 2020, raises hopes.Strong Solvency: Insulet exited the second quarter of 2021 with cash and cash equivalents, and short-term investments of $872.1 million. At the end of the reported quarter, total debt was $1.26 billion. Although the quarter’s total debt was much higher than the corresponding cash and cash equivalent level, the company's short-term-payable debt of $21 million is significantly lower than the cash and cash equivalents, and short-term investments. This is good news for the company's solvency position, since at least during the year of economic downturn, the company is holding enough cash for short-term debt repayment.Q2 Upsides:  We are upbeat about Insulet’s better-than-expected revenues in the second quarter of 2021. The solid uptake of the Omnipod system, both in the United States and international markets, drove the top line. The company’s second-quarter U.S. Omnipod revenues increased robustly year over year, meeting the low end of the guidance on strength in total Omnipod growth. Insulet’s plan to introduce the Omnipod 5 in the second half of 2021 looks encouraging as well. The full-year revenue guidance with strong growth projection over 2020 buoys optimism.DownsidesSole Reliance on Omnipod System: Insulet’s financial performance continues to be largely dependent on the performance of its lead product, the Omnipod System. Per the company, any adverse change in the market acceptance of the product or worsening of the factors that negatively influence sales will have a significant impact on the company’s financials.Economic Uncertainty Impedes Growth: Weaker global economic conditions may reduce demand for Insulet’s products and intensify competition. A number of countries in Western Europe are facing a liquidity crunch. Insulet is also exposed to the risk of a reduction in healthcare spending in the United States, Canada and Europe due to an economic slump. Unstable macroeconomic conditions due to the coronavirus outbreak is concerning as well.Tough Competitive Pressure: Insulet operates in a highly competitive environment, dominated by firms ranging from large multinational corporations to start-ups. Also, the competitive and regulatory conditions in the markets where the company operates limit Insulet’s ability to switch to strategies like price increases and other drivers of cost. Insulet’s Omnipod System primarily competes with MiniMed, a division of Medtronic PLC MDT.Estimate TrendInsulet has been witnessing a negative estimate revision trend for 2021. Over the past 30 days, the Zacks Consensus Estimate for its earnings per share has moved down by 16.7% to 20 cents.The Zacks Consensus Estimate for Insulet’s third-quarter 2021 revenues is pegged at $270.9 million, suggesting a 15.8% rise from the year-ago reported number.Key PicksTwo better-ranked stocks from the Medical-Products include VAREX IMAGING VREX and Envista Holdings Corporation NVST, each carrying a Zacks Rank #2 (Buy).VAREX has a long-term earnings growth rate of 5%.You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Envista Holdings has a long-term earnings growth rate of 27.4%. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Medtronic PLC (MDT): Free Stock Analysis Report Insulet Corporation (PODD): Free Stock Analysis Report VAREX IMAGING (VREX): Free Stock Analysis Report Envista Holdings Corporation (NVST): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 24th, 2021

Williams-Sonoma (WSM) Up 1% Since Last Earnings Report: Can It Continue?

Williams-Sonoma (WSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. A month has gone by since the last earnings report for Williams-Sonoma (WSM). Shares have added about 1% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Williams-Sonoma due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Williams-Sonoma (WSM) Q2 Earnings Beat Estimates, View UpWilliams-Sonoma Inc. reported solid second-quarter fiscal 2021 results, wherein earnings and revenues handily beat the Zacks Consensus Estimate and significantly increased year over year, courtesy of strength across all brands along with accelerated e-commerce growth.Meanwhile, it lifted fiscal 2021 outlook once again, courtesy of encouraging macro trends.Laura Alber, the company’s president and chief executive officer, said, “We believe we are at the intersection of a transformative change that will accelerate the growth of our industry, and our market share within the industry. In addition, our growth strategies are gaining traction faster than we predicted, and our key differentiators are further distancing us from our competition."Earnings & RevenuesNon-GAAP adjusted earnings of $3.24 per share surpassed the Zacks Consensus Estimate of $2.55 by 27.1%. The figure also increased 80% from $1.80 per share reported a year ago.Revenues of $1,948.3 million beat the consensus mark of $1,802 million by 8.1% and grew 30.7% year over year. The better-than-expected revenues were driven by solid comparable brand revenue growth and e-commerce penetration.Comps increased 29.8% versus 10.5% growth in the year-ago period. Comps at West Elm increased an impressive 51.1% compared with 7% growth registered in the prior-year quarter. Comps in the Pottery Barn brand grew 29.6% versus 8.1% growth in the prior-year quarter. Williams Sonoma brand’s comps rose 6.4% compared with 29.4% growth in the year-ago quarter. Pottery Barn Kids and Teen’s comps rose 18% versus 4.8% growth in the year-ago quarter.Also, e-commerce penetration accounted for 65% of total revenues, buoyed by its in-house tech platform, rapid experimentation program, content-rich online experience and marketing strategies.Operating HighlightsNon-GAAP gross margin was 44.1%, up 710 bps from the year-ago period. The upside was primarily caused by higher merchandise margins and occupancy leverage in the quarter.Non-GAAP selling, general and administrative expenses were 27.3% of net revenues compared with 23.9% in the year-ago quarter, reflecting an increase of 340 bps. The upside was driven by robust top-line performance and ongoing financial and operational strategies, partly offset by higher advertising spending. Furthermore, non-GAAP operating margin expanded 360 bps from the year-ago period to 16.7% for the quarter.FinancialsWilliams-Sonoma reported cash and cash equivalents of $655.2 million as of Aug 1, 2021 compared with $1,200.3 million at fiscal 2020-end. For the second quarter, its capital expenditure was $36 million. Williams-Sonoma returned more than $180 million to shareholders in the form of $45 million in dividends and $135 million in share repurchases.Raised Fiscal 2021 GuidanceThe company is optimistic about business strength, and anticipates recovery in retail traffic as well as inventory levels during fiscal 2021.For fiscal 2021, Williams-Sonoma now expects revenues to witness high-teens to low-twenties net revenue growth versus low double-digit to mid-teen improvement expected earlier. It also expects non-GAAP operating margin between 16% and 17% for the year.Furthermore, the company now projects revenue acceleration to $10 billion over the next four years (a year earlier than previous projection).How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended upward during the past month. The consensus estimate has shifted 15.57% due to these changes.VGM ScoresAt this time, Williams-Sonoma has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the top 40% for this investment strategy.Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Williams-Sonoma has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report WilliamsSonoma, Inc. (WSM): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

Stock Market News for Sep 24, 2021

Wall Street ended Thursday with a sharp rally after an impressive performance on the previous day. Wall Street ended Thursday with a sharp rally after an impressive performance on the previous day. Market participants seemed relieved after the Fed’s FOMC meeting decision, broadly in line with expectations. All three major stock indexes finished in positive territory.How Did The Benchmarks Perform?The Dow Jones Industrial Average (DJI) advanced 1.5% or 506.50 points to close at 34,764.82. Notably, 27 components of the 30-stock index ended in the green while 3 in red. This was the blue-chip index’s best two straight-day performance since Mar 8.The tech-heavy Nasdaq Composite finished at 15,052.24, rising 1% or 155.40 points due to strong performance by large-cap technology stocks. This was the teach-laden index’s first closing above 15,000 since Sep 17.Meanwhile, the S&P 500 gained 1.2% to end at 4,448.98. The Energy Select Sector SPDR (XLE), the Financials Select Sector SPDR (XLF), the Technology Select Sector SPDR (XLK), the Consumer Discretionary Select Sector (SPDR), the Materials Select Sector SPDR (XLB) and the Communication Services Select Sector SPDR (XLC) climbed 3.5%, 2.5%, 1.3%, 1%, 1.4% and 1%, respectively. Nine out of eleven sectors of the benchmark index closed in positive territory while two ended in red.The fear-gauge CBOE Volatility Index (VIX) dropped 10.7% to 18.63. A total of 9.84 billion shares were traded on Thursday, lower than the last 20-session average of 10.07 billion. Advancers outnumbered decliners on the NYSE by a 1.91-to-1 ratio. On Nasdaq, a 2.66-to-1 ratio favored advancing issues.Concerns Over Fed EaseInvestors appeared relieved on the Fed’s stance on dovish monetary policies. Fed Chairman Jerome Powell’s confirmation that a shift from the central bank’s ultra-dovish monetary policy is not imminent, boosted investors’ confidence.The Fed will maintain its monetary stimulus and will stick to a near-zero short-term benchmark interest rate at least for the time being. In his statement after the conclusion of the two-day FOMC meeting, Fed Chairman Jerome Powell said “If progress continues broadly as expected, the Committee judges that a moderation in the pace of asset purchases may soon be warranted.”Fed’s latest dot plot for rate projection is showing nine out 18 members believe that the first-rate cut will come in the second half of 2022. This number was just seven after June’s FOMC meeting. Although the Fed restrained from providing any timeline when the tapering of the monthly $120 billion bond-buy program will start, many industry watchers believe that the announcement will come in the next FOMC meeting in November and the process will start from December.As investors shifted funds to risky assets like equities from safe-haven government bonds, demand for bonds fell and prices dropped. As a result, yield on the benchmark 10-Year U.S. Treasury Note moved up 11.6 basis points to 1.427%. Higher market risk-free interest rate bodes well for financial sector.Consequently, shares of major banks like JPMorgan Chase & Co. JPM, Bank of America Corp. BAC and Citigroup Inc. C surged 3.4%, 3.9% and 3.9%, respectively. All three stocks carry a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Economic DataThe Department of Labor reported that weekly jobless claims rose to 351,000 compared with the consensus estimate of 319,000, for the week ended Sep 18. Previous week’s data was revised upward to 335,000 from 332,000 reported earlier. Continuing claims (those who have already received benefits) increased 131,000 to 2.845 million for the week ended Sep 11.The four-week moving average that smoothed out weekly fluctuations, came down 750 to 335,750, marking the lowest since March 2020. As of Sep 4, around 11.3 million people were reportedly receiving benefits through eight separate state or federal programs, marking a decrease of 900,000 from the previous week.The Conference Board Reported the leading indicators of the U.S. economy gained 0.9% in August to a reading of 117.1. The consensus estimate was 0.7%. July’s gain was revised downward to 0.8% from 0.9% reported earlier.IHS Markit reported that its flash U.S. Composite Output Index for the month of September dropped to a 12-month low of 54.5 from 55.4 in August. Any reading above 50 indicates expansions in overall economic activities. The U.S. services index declined 1.1 points to a 14-month low of 54.4 while the U.S. manufacturing index fell 0.6 points to a 5-month low of 60.5. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bank of America Corporation (BAC): Free Stock Analysis Report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Citigroup Inc. (C): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 24th, 2021

Leaders at Moderna and AstraZeneca are offering new, rosy predictions about the pandemic"s end

Vaccine makers and public-health experts think the COVID-19 pandemic will probably end next year in the US. An employee at the Vermont Creamery receiving a COVID-19 vaccine from the National Guard at a pop-up stand in Websterville, Vermont, on June 29, 2021. Ed Jones/AFP via Getty Images Vaccine makers have recently said they think the pandemic will finally end in 2022. A lead scientist behind AstraZeneca's vaccine predicted that the coronavirus will likely become similar to the common cold. See more stories on Insider's business page. Top brass at Moderna and AstraZeneca have recently offered rosy predictions about what's in store for the coronavirus."If you look at the industry-wide expansion of production capacities over the past six months, enough doses should be available by the middle of next year so that everyone on this Earth can be vaccinated," Stéphane Bancel, the CEO of Moderna, told the Swiss newspaper the Neue Zürcher Zeitung, Reuters reported Thursday."Those who do not get vaccinated will immunize themselves naturally, because the Delta variant is so contagious," Bancel added. "In this way we will end up in a situation similar to that of the flu. You can either get vaccinated and have a good winter. Or you don't do it and risk getting sick and possibly even ending up in hospital."In response to a question about when the pandemic would end, Bancel replied, "As of today, in a year, I assume."Sarah Gilbert, the scientist who led the team that developed the Oxford/AstraZeneca vaccine, echoed similar sentiments during a Royal Society of Medicine webinar on Wednesday."We already live with four different human coronaviruses that we don't really ever think about very much, and eventually Sars-CoV-2 will become one of those," Gilbert said, according to the Evening Standard.Common human coronaviruses, like the one that causes the common cold, typically cause mild-to-moderate upper respiratory illness.Albert Bourla, Pfizer's CEO, also commented on the the future of global vaccine distribution this week."We will see a billion doses by the end of this year, not in the near future, by the end of this year," he said in interview with CNBC's "Squawk Box" on Wednesday. "And we will do at least 1 billion doses next year, and I think the facts are speaking for themselves."The comments come at a moment when more and more industry and public-health leaders in the US are issuing hopeful messages, despite the recent Delta surge. Though of course, plenty of predictions about the pandemic have been proven wrong before.What is 'returning to normal' anyway?Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security, told Insider that Bancel's projection seems mostly on target. "This acute phase of the pandemic will likely wind down within 2022," Adalja said. "As more people have natural immunity and as more people are vaccinated, that's going to cause the public-health emergency to no longer be in effect for the world - when the virus is unable to cause as much serious disease, hospitalization and death as it has been able to in this phase of the pandemic." Bible-Based Fellowship Church, the Pasco County Health Department, and the Army National Guard teamed up to administer the Moderna vaccine in Tampa, Florida, on February 13, 2021. Octavio Jones/Getty Images John Brownstein, an epidemiologist at Boston Children's Hospital, similarly said he sees "reason to be optimistic that we may be out of the pandemic."The dark horse, Brownstein told Insider, is the possibility of a new variant that could evade our vaccines. "We've been surprised by this pandemic over and over again," he said, adding, "to put any timeframe on it would likely mean that you'd be 100% wrong."To that point, Bancel's predictions about when the pandemic would end have been wrong in the past. In November, Bancel told Insider that he envisioned a return to normal in summer 2021. Bourla, too, gave a prediction in June - before the spike in infections tied to Delta - that will most likely turn out to be too optimistic. Bourla told CNBC that he thought developed countries could return to normal life by the end of 2021, and the rest of the world in 2022.Part of the difficulty, though, is that there's no standard definition of what "returning to normal" means. Many people in the US - including this reporter - envision it as a return to everyday life close to the way Americans were living it in 2019. No need to work from home. Relatively low risk at large gatherings like concerts and weddings. No mask requirements. Bancel's definition may be less rigid."Is it a return to baseline?" Brownstein asked. "Or is it a new baseline?"A new normal may be a more realistic target. "I think that what you'll see is the normalization of COVID-19 and how people learn to cope with it," Adalja said. "COVID's not going anywhere and people are learning to adjust."Adalja already has."I'm back to my normal life, except I take care of COVID patients," he said.Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 24th, 2021

Here"s How Investors Can Find Strong Retail and Wholesale Stocks with the Zacks ESP Screener

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among the rest: earnings.Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises.Hunting for 'earnings whispers' or companies poised to beat their quarterly earnings estimates is a somewhat common practice. But that doesn't make it easy. One way that has been proven to work is by using the Zacks Earnings ESP tool.The Zacks Earnings ESP, ExplainedThe Zacks Earnings ESP is more formally known as the Expected Surprise Prediction, and it aims to grab the inside track on the latest analyst estimate revisions ahead of a company's report. The idea is relatively intuitive as a newer projection might be based on more complete information.Now that we understand the basic idea, let's look at how the Expected Surprise Prediction works. The ESP is calculated by comparing the Most Accurate Estimate to the Zacks Consensus Estimate, with the percentage difference between the two giving us the Zacks ESP figure.Bringing together a positive earnings ESP alongside a Zacks Rank #3 (Hold) or better has helped stocks report a positive earnings surprise 70% of the time. Furthermore, by using these parameters, investors have seen 28.3% annual returns on average, according to our 10 year backtest.Stocks with a ranking of #3 (Hold), or 60% of all stocks covered by the Zacks Rank, are expected to perform in-line with the broader market. Stocks with rankings of #2 (Buy) and #1 (Strong Buy), or the top 15% and top 5% of stocks, respectively, should outperform the market; Strong Buy stocks should outperform more than any other rank.Should You Consider CarMax?The last thing we will do today, now that we have a grasp on the ESP and how powerful of a tool it can be, is to quickly look at a qualifying stock. CarMax (KMX) holds a #3 (Hold) at the moment and its Most Accurate Estimate comes in at $1.90 a share six days away from its upcoming earnings release on September 30, 2021.By taking the percentage difference between the $1.90 Most Accurate Estimate and the $1.89 Zacks Consensus Estimate, CarMax has an Earnings ESP of 0.17%. Investors should also know that KMX is just one of a large group of stocks with positive ESPs. All of these qualifying stocks can be filtered by ESP, Zacks Rank, % Surprise (Last Qtr.), and Reporting date.Now that you know how to use the Zacks Earnings ESP to your advantage, make sure to check out the Earnings ESP Home Page for even more earnings related strategies to create a winning portfolio.Find Stocks to Buy or Sell Before They're ReportedUse the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >> Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CarMax, Inc. (KMX): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

Sysco"s (SYY) Cutting Edge Solutions Products to Fuel Growth

Sysco (SYY) unveils eight innovative concepts through the company's Cutting Edge Solutions platform, which is likely to enhance its customers' experience. Sysco Corporation SYY has been committed toward enriching the experience of its customers. Progressing along these lines, the marketer and distributor of several food and related products made the countrywide launch of eight innovative concepts through its Cutting Edge Solutions platform, solely for customers.These unique products will offer foodservice operators trendy menu choices, including plant-based ingredients, alongside providing innovative to-go solutions. We note that Sysco’s Cutting Edge Solutions platform enables its customers to keep pace with the changing trends and stand apart in the foodservice space by providing innovative offerings for dine-in; takeout or delivery, alongside offering labor-saving solutions.Management stated that the company’s Cutting Edge Solutions products for fall 2021 are available now. These include innovative and take-out friendly options like Sysco Classic Tamper Evident Fry Containers and SAVRpak; comfort foods such as Sysco’s Imperial Mashup Desserts; on-demand plant-based choices like Sysco Simply Plant-Based Sprouted Hamburger Buns, Sysco’s Simply Plant-Based Protein and Sysco Simply Plant-Based Cauliflower Tortillas; environment-friendly and sustainable products including Sysco’s Earth Plus 100% Recycled Hot Cups; as well as the Sysco’s Classic Sous-Vide Sirloin Steak menu option, which will help operators save labor costs.Image Source: Zacks Investment ResearchSysco Focused on GrowthSysco has been focused on transforming into a more growth-oriented, customer-focused and innovative company. To this end, the company unveiled its Recipe for Growth in May 2021, which involves five strategic priorities aimed at enabling Sysco to grow 1.5 times faster than the market by the end of fiscal 2024. Sysco is progressing well with its Recipe for Growth and is on track to generate cost curtailments of $750 million for the period from fiscal 2021 to fiscal 2024. Notably, Sysco exceeded its cost-saving target of $350 million in fiscal 2021.The five above-mentioned strategic pillars include enhancing customers’ experience via digital tools. In this regard, the company’s Sysco Shop platform and the new pricing software are working well. Moving on, the company is focused on improving the supply chain to cater to customers efficiently and consistently, on the back of better delivery and omnichannel inventory management. Next, Sysco aims at providing customer-oriented merchandising and marketing solutions to boost sales. The company also targets having team-based selling, with emphasis on the important cuisines. Finally, Sysco is focused on cultivating new capacities, channels and segments, alongside sponsoring investments via its cost-saving initiatives.Such growth efforts along with gains from acquisitions have been driving the company, which raised its earnings per share guidance for fiscal 2022, when it reported the fourth-quarter fiscal 2021 results. Robust fourth-quarter sales along with stringent management of inflation and costs encouraged management to raise its earnings view. Management now envisions earnings per share to come in the range of $3.33-$3.53 in fiscal 2022, up from the earlier projection of $3.23-$3.43.Clearly, Sysco’s constant growth efforts, such as the latest launch under its Cutting Edge Solutions platform, are likely to keep the company well positioned. The Zacks Rank #2 (Buy) stock has rallied 9.4% so far this year, outpacing the industry’s rise of 2.2%. 3 Other Delicious PicksThe Zacks #1 (Strong Buy) Ranked J&J Snack Foods’ JJSF bottom line has outpaced the Zacks Consensus Estimate by a wide margin in the preceding four quarters. You can see the complete list of today’s Zacks #1 Rank stocks here.Darling Ingredients DAR, also sporting a Zacks Rank #1, has a trailing four-quarter earnings surprise of 39.1%, on average.Medifast, Inc. MED, currently carrying a Zacks Rank #2, has a trailing four-quarter earnings surprise of around 16%, on average. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Darling Ingredients Inc. (DAR): Free Stock Analysis Report Sysco Corporation (SYY): Free Stock Analysis Report J & J Snack Foods Corp. (JJSF): Free Stock Analysis Report MEDIFAST INC (MED): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 24th, 2021

Leaders at Moderna and AstraZeneca, are offering new, rosy predictions about the pandemic"s end

Vaccine makers and public-health experts think the COVID-19 pandemic will probably end next year in the US. An employee at the Vermont Creamery receives a COVID-19 vaccine from the National Guard at a pop-up stand in Websterville, Vermont, on June 29, 2021. Ed Jones/AFP via Getty Images Vaccine makers have recently said they think the pandemic will finally end in 2022. A lead scientist behind AstraZeneca's vaccine predicted that the coronavirus will likely become similar to the common cold. See more stories on Insider's business page. Top brass at Moderna and AstraZeneca have recently offered rosy predictions about what's in store for the coronavirus."If you look at the industry-wide expansion of production capacities over the past six months, enough doses should be available by the middle of next year so that everyone on this Earth can be vaccinated," Stéphane Bancel, the CEO of Moderna, told the Swiss newspaper the Neue Zürcher Zeitung, Reuters reported Thursday."Those who do not get vaccinated will immunize themselves naturally, because the Delta variant is so contagious," Bancel added. "In this way we will end up in a situation similar to that of the flu. You can either get vaccinated and have a good winter. Or you don't do it and risk getting sick and possibly even ending up in hospital."In response to a question about when the pandemic would end, Bancel replied, "As of today, in a year, I assume."Sarah Gilbert, the scientist who led the team that developed the Oxford/AstraZeneca vaccine, echoed similar sentiments during a Royal Society of Medicine webinar on Wednesday."We already live with four different human coronaviruses that we don't really ever think about very much, and eventually Sars-CoV-2 will become one of those," Gilbert said, according to the Evening Standard.Common human coronaviruses, like the one that causes the common cold, typically cause mild-to-moderate upper respiratory illness.Albert Bourla, Pfizer's CEO, also commented on the the future of global vaccine distribution this week."We will see a billion doses by the end of this year, not in the near future, by the end of this year," he said in interview with CNBC's "Squawk Box" on Wednesday. "And we will do at least 1 billion doses next year, and I think the facts are speaking for themselves."The comments come at a moment when more and more industry and public-health leaders in the US are issuing hopeful messages, despite the recent Delta surge. Though of course, plenty of predictions about the pandemic have been proven wrong before.What is 'returning to normal' anyway?Dr. Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security, told Insider that Bancel's projection seems mostly on target. "This acute phase of the pandemic will likely wind down within 2022," Adalja said. "As more people have natural immunity and as more people are vaccinated, that's going to cause the public-health emergency to no longer be in effect for the world - when the virus is unable to cause as much serious disease, hospitalization and death as it has been able to in this phase of the pandemic." Bible-Based Fellowship Church, the Pasco County Health Department, and the Army National Guard teamed up to administer the Moderna vaccine in Tampa, Florida, on February 13, 2021. Octavio Jones/Getty Images John Brownstein, an epidemiologist at Boston Children's Hospital, similarly said he sees "reason to be optimistic that we may be out of the pandemic."The dark horse, Brownstein told Insider, is the possibility of a new variant that could evade our vaccines. "We've been surprised by this pandemic over and over again," he said, adding, "to put any timeframe on it would likely mean that you'd be 100% wrong."To that point, Bancel's predictions about when the pandemic would end have been wrong in the past. In November, Bancel told Insider that he envisioned a return to normal in summer 2021. Bourla, too, gave a prediction in June - before the spike in infections tied to Delta - that will most likely turn out to be too optimistic. Bourla told CNBC that he thought developed countries could return to normal life by the end of 2021, and the rest of the world in 2022.Part of the difficulty, though, is that there's no standard definition of what "returning to normal" means. Many people in the US - including this reporter - envision it as a return to everyday life close to the way Americans were living it in 2019. No need to work from home. Relatively low risk at large gatherings like concerts and weddings. No mask requirements. Bancel's definition may be less rigid."Is it a return to baseline?" Brownstein asked. "Or is it a new baseline?"A new normal may be a more realistic target. "I think that what you'll see is the normalization of COVID-19 and how people learn to cope with it," Adalja said. "COVID's not going anywhere and people are learning to adjust."Adalja already has."I'm back to my normal life, except I take care of COVID patients," he said.Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 24th, 2021

Bear of the Day: Blue Bird Corporation (BLBD)

Most U.S. schools are back in person and the company could rebound in the next few years. However, its near-term outlook is hardly strong and its stock is down 25% in the last three months. Blue Bird Corporation BLBD is a historic maker of school buses and it’s expanded its offerings to include alternative fuel and EV buses. The stock went on a huge run after the vaccine announcement last fall as Wall Street cheered the likelihood schools would reopen soon.  Most U.S. schools are back in person and the company could rebound in the next few years. However, its near-term outlook is hardly strong and its stock is down 25% in the last three months.Blue Bird Basics Blue Bird is a leading independent designer and manufacturer of school buses, with roughly 180,000 buses in operation today. The company is rather stable and has remained a staple in American school districts for decades.BLBD’s sales had grown over the last several years before they slipped marginally in FY19 and then dropped 14% in fiscal 2020 (period ended Oct. 3, 2020), as the entire education world was turned upside down.Zacks estimates call for its fiscal 2021 revenue to fall another 17% to $730 million, with its adjusted earnings projected to sink 51% to $0.40 a share. Luckily, the company is projected to bounce back in 2022, with its EPS expected to surge 75% above our current year projection on 11% higher sales.Image Source: Zacks Investment ResearchBottom LineDespite the expected progress, Blue Bird’s earnings revisions have trended in the wrong direction to help it land a Zacks Rank #5 (Strong Sell) at the moment, alongside its “D” grades for Value and Momentum and an “F” for Growth in our Style Score system.On top of that, its Automotive – Domestic industry is near the bottom quarter of over 250 Zacks industries. And the nearby chart showcases that Blue Bird stock has significantly underperformed its industry in the past three years, while falling 19%.The Macon, Georgia company is set to bounce back as life and schools return to normal. The firm could also benefit as it sells more electric school buses and more districts slowly revamp their fleets as part of a broader green push.All that said, investors might want to stay away from BLBD stock for now, or at least until it shows signs of a more prolonged comeback. Time to Invest in Legal Marijuana If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027. After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%. You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Blue Bird Corporation (BLBD): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksSep 24th, 2021

Deere (DE) Gains From Farm Equipment Demand & Investment

Deere (DE) is well placed to benefit from robust farm equipment demand, driven by higher commodity prices, upbeat construction demand as well as focus on investment in precision farming technology. On Sep 22, we issued an updated research report on Deere & Company DE. The company will gain from higher agricultural commodity prices that will likely spur agricultural equipment demand in the near term. An improved scenario in the construction sector as well as focus on investments in precision agriculture will continue to aid growth.Higher Commodity Prices to Drive GrowthAccording to the USDA’s (U.S Department of Agriculture) farm income forecast, the net farm income is anticipated to increase 19.5% from 2020 to $113 billion in the current year — the highest level since 2013. This upbeat projection is primarily owing to the higher commodity prices on account of the tightening global stocks and strong import demand from China through the year. In inflation-adjusted 2021 dollars, the net farm income is forecast to increase 15.3% in the ongoing year. The increased commodity prices will drive farm income, encouraging farmers to boost spending on the new agricultural equipment and replace their aging fleets. This, in turn, will boost Deere's top line.The company expects to see solid double-digit growth in production rates for crop care products in fiscal 2022. While government support is expected to decrease this year, total crop cash receipts in the United States will likely be up 19.7% on higher commodity prices, primarily soybean and corn. The U.S customer sentiment has gone up over the last few quarters with elevated exports to China. Considering these factors, Deere projects the fiscal 2021 net income in the band of $5.7-$5.9 billion, up from the prior guidance of $5.3 billion to $5.7 billion.Upbeat Farm Equipment Sales Forecast Bodes WellFor the Agriculture & Turf segment, the company expects industry sales of large agricultural equipment in the United States and Canada to be up roughly 25% in fiscal 2021, and small agricultural and turf equipment to be up 10%. In Europe, the industry is projected to be up around 10-15% as higher commodity prices favored business conditions in the arable segment. In South America, the industry sales of tractors and combines are likely to go up 20%. Industry sales in Asia are forecast to be up significantly, driven primarily by a strong recovery in the Indian tractor market.Net sales for Deere’s Production and Precision Agriculture segment are anticipated to be up between 25% and 30% in fiscal 2021. The segment’s operating margin is estimated between 20% and 21%.The company has also been witnessing improvement in the Construction & Forestry segment. The North American construction equipment industry sales are expected to be up between 15% and 20%, while the sales of compact construction equipment are estimated to be up between 20% and 25%. The Forestry equipment sales are expected to be up 15%, as lumber demand remains robust.Sales for the Construction & Forestry segment are projected to be up 30% and the operating margin is likely to be 12% to 13% in fiscal 2021. The company is likely to benefit from growth in non-residential investment and a strong order activity from independent rental companies during the fiscal fourth quarter.Advanced Farming Technology to Spur GrowthDeere is well poised for growth over the long term, backed by steady investments in new products and geographies. Focus on launching innovative products equipped with advanced technologies and features, and investments in precision agriculture provide it a competitive edge. The company envisions to revolutionize agriculture with technology and make farming automated, easy to use and more precise across the production process. Farmers’ growing reliance on advanced technology to run their complex operations smoothly will continue to fuel Deere’s revenues.Share Price PerformanceDeere’s shares have gained 27.3% so far this year, outperforming the industry’s growth of 21.9%.Image Source: Zacks Investment ResearchZacks Rank and Other Stocks to ConsiderDeere currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Other top-ranked stocks in the Industrial Products sector include Encore Wire Corporation WIRE, Alcoa Corporation AA and Lincoln Electric Holdings, Inc. LECO. While Encore Wire and Alcoa sport a Zacks Rank #1, Lincoln Electric carries a Zacks Rank #2, at present.Encore Wire has a projected earnings growth rate of 332.6% for fiscal 2021. So far this year, the company’s shares have gained 45%.Alcoa has an estimated earnings growth rate of 573.2% for 2021. The company’s shares have rallied 108%, so far this year.Lincoln Electric has an expected earnings growth rate of 45.1% for 2021. The stock has appreciated 22%, year to date. More Stock News: This Is Bigger than the iPhone! It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market. Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.Click here for the 4 trades >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alcoa Corp. (AA): Free Stock Analysis Report Deere & Company (DE): Free Stock Analysis Report Lincoln Electric Holdings, Inc. (LECO): Free Stock Analysis Report Encore Wire Corporation (WIRE): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 23rd, 2021

NIO Inc. (NIO) Gains But Lags Market: What You Should Know

In the latest trading session, NIO Inc. (NIO) closed at $36.01, marking a +0.87% move from the previous day. NIO Inc. (NIO) closed at $36.01 in the latest trading session, marking a +0.87% move from the prior day. The stock lagged the S&P 500's daily gain of 1.21%.Prior to today's trading, shares of the company had lost 8.34% over the past month. This has lagged the Auto-Tires-Trucks sector's gain of 6.34% and the S&P 500's loss of 0.9% in that time.NIO will be looking to display strength as it nears its next earnings release.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.79 per share and revenue of $5.36 billion. These totals would mark changes of -19.7% and +123%, respectively, from last year.Investors should also note any recent changes to analyst estimates for NIO. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 10.23% lower. NIO is currently sporting a Zacks Rank of #4 (Sell).The Automotive - Foreign industry is part of the Auto-Tires-Trucks sector. This group has a Zacks Industry Rank of 103, putting it in the top 41% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. More Stock News: This Is Bigger than the iPhone! It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market. Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.Click here for the 4 trades >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NIO Inc. (NIO): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 23rd, 2021

Pinterest (PINS) Stock Sinks As Market Gains: What You Should Know

Pinterest (PINS) closed the most recent trading day at $54.02, moving -0.3% from the previous trading session. In the latest trading session, Pinterest (PINS) closed at $54.02, marking a -0.3% move from the previous day. This move lagged the S&P 500's daily gain of 1.21%.Prior to today's trading, shares of the digital pinboard and shopping tool company had lost 3.54% over the past month. This has lagged the Computer and Technology sector's gain of 1.28% and the S&P 500's loss of 0.9% in that time.PINS will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of $0.24, up 84.62% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $627.57 million, up 41.79% from the prior-year quarter.For the full year, our Zacks Consensus Estimates are projecting earnings of $1.09 per share and revenue of $2.65 billion, which would represent changes of +159.52% and +56.27%, respectively, from the prior year.Any recent changes to analyst estimates for PINS should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. PINS is holding a Zacks Rank of #2 (Buy) right now.In terms of valuation, PINS is currently trading at a Forward P/E ratio of 49.56. For comparison, its industry has an average Forward P/E of 58.18, which means PINS is trading at a discount to the group.The Internet - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 207, putting it in the bottom 19% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.To follow PINS in the coming trading sessions, be sure to utilize Zacks.com. More Stock News: This Is Bigger than the iPhone! It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market. Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.Click here for the 4 trades >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pinterest, Inc. (PINS): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 23rd, 2021